Celadon Pharmaceuticals to Delist From AIM

Dow Jones

Mar 24, 2025

By Elena Vardon

Celadon Pharmaceuticals is set to delist from London's AIM after its directors resigned.

The medical cannabis firm on Monday said that it will propose to move ahead with the cancellation of trading of its shares at a general meeting.

This follows a proposal put forward on Wednesday by Chief Executive James Short--who owns 39.5% of the company--to remove four non-executive directors and Chairman Alexander Anton. The board hadn't been supportive of Short's proposal to delist to reduce operational costs and access capital on easier and more attractive terms.

On Friday, directors Robert Barr, Elizabeth Shanahan, David Firth and Steven Hajioff resigned following talks, it said.

Anton is reviewing his position as chair and will resign from the board if the cancellation is approved by shareholders, Celadon added.

Write to Elena Vardon at elena.vardon@wsj.com

(END) Dow Jones Newswires

March 24, 2025 03:41 ET (07:41 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2521762103"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2521762103\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2521762103?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-03-24 15:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2521762103","market":"other","top_or_hot":-1,"title":"Celadon Pharmaceuticals to Delist From AIM","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Elena Vardon \n</p>\n<pre>\n \n</pre>\n<p>\n  Celadon Pharmaceuticals is set to delist from London's AIM after its directors resigned. \n</p>\n<p>\n  The medical cannabis firm on Monday said that it will propose to move ahead with the cancellation of trading of its shares at a general meeting. \n</p>\n<p>\n  This follows a proposal put forward on Wednesday by Chief Executive James Short--who owns 39.5% of the company--to remove four non-executive directors and Chairman Alexander Anton. The board hadn't been supportive of Short's proposal to delist to reduce operational costs and access capital on easier and more attractive terms. \n</p>\n<p>\n  On Friday, directors Robert Barr, Elizabeth Shanahan, David Firth and Steven Hajioff resigned following talks, it said. \n</p>\n<p>\n  Anton is reviewing his position as chair and will resign from the board if the cancellation is approved by shareholders, Celadon added. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Elena Vardon at elena.vardon@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 24, 2025 03:41 ET (07:41 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Celadon Pharmaceuticals to Delist From AIM</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCeladon Pharmaceuticals to Delist From AIM\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-03-24 15:41</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Elena Vardon \n</p>\n<pre>\n \n</pre>\n<p>\n  Celadon Pharmaceuticals is set to delist from London's AIM after its directors resigned. \n</p>\n<p>\n  The medical cannabis firm on Monday said that it will propose to move ahead with the cancellation of trading of its shares at a general meeting. \n</p>\n<p>\n  This follows a proposal put forward on Wednesday by Chief Executive James Short--who owns 39.5% of the company--to remove four non-executive directors and Chairman Alexander Anton. The board hadn't been supportive of Short's proposal to delist to reduce operational costs and access capital on easier and more attractive terms. \n</p>\n<p>\n  On Friday, directors Robert Barr, Elizabeth Shanahan, David Firth and Steven Hajioff resigned following talks, it said. \n</p>\n<p>\n  Anton is reviewing his position as chair and will resign from the board if the cancellation is approved by shareholders, Celadon added. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Elena Vardon at elena.vardon@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 24, 2025 03:41 ET (07:41 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2521762103","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2521762103","pubTimestamp":1742802060,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Celadon Pharmaceuticals is set to delist from London's AIM after its directors resigned.The medical cannabis firm on Monday said that it will propose to move ahead with the cancellation of trading of its shares at a general meeting.This follows a proposal put forward on Wednesday by Chief Executive James Short--who owns 39.5% of the company--to remove four non-executive directors and Chairman Alexander Anton. The board hadn't been supportive of Short's proposal to delist to reduce operational costs and access capital on easier and more attractive terms.On Friday, directors Robert Barr, Elizabeth Shanahan, David Firth and Steven Hajioff resigned following talks, it said.Anton is reviewing his position as chair and will resign from the board if the cancellation is approved by shareholders, Celadon added.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","BK4557":"大麻股","AIM":"AIM ImmunoTech Inc.","CGI":"萨拉东"},"translate_title":"青瓷制药将从AIM退市","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CGI":1,"AIM":1},"content_text":"By Elena Vardon \n\n\n \n\n\n  Celadon Pharmaceuticals is set to delist from London's AIM after its directors resigned. \n\n\n  The medical cannabis firm on Monday said that it will propose to move ahead with the cancellation of trading of its shares at a general meeting. \n\n\n  This follows a proposal put forward on Wednesday by Chief Executive James Short--who owns 39.5% of the company--to remove four non-executive directors and Chairman Alexander Anton. The board hadn't been supportive of Short's proposal to delist to reduce operational costs and access capital on easier and more attractive terms. \n\n\n  On Friday, directors Robert Barr, Elizabeth Shanahan, David Firth and Steven Hajioff resigned following talks, it said. \n\n\n  Anton is reviewing his position as chair and will resign from the board if the cancellation is approved by shareholders, Celadon added. \n\n\n \n\n\n  Write to Elena Vardon at elena.vardon@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 24, 2025 03:41 ET (07:41 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}